azacitidine has been researched along with enzastaurin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Hagiwara, K; Ito, H; Miyata, Y; Murate, T; Nagai, H; Ohashi, H | 1 |
2 other study(ies) available for azacitidine and enzastaurin
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
Topics: Animals; Azacitidine; Cell Proliferation; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Profiling; HCT116 Cells; HeLa Cells; Homeodomain Proteins; Humans; Indoles; Male; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Protein Kinase C; Protein Kinase C beta; Sp1 Transcription Factor; Tumor Suppressor Proteins | 2012 |